Home
DWTX
DWTX News

Latest DOGWOOD THERAPEUTICS INC (DWTX) News on December 25, 2024

Dogwood Therapeutics, Inc. Announces Low Dose IMC-2 Treatment Reduces Long-COVID Related Fatigue and Sleep Disturbance in an Investigator-Initiated Study

GlobeNewswire

a month ago

Dogwood Therapeutics, Inc. Announces Low Dose IMC-2 Treatment Reduces Long-COVID Related Fatigue and Sleep Disturbance in an Investigator-Initiated Study

MT Newswires

a month ago

Top Premarket Decliners

DWTX: Phase 2 Long COVID Results Expected Soon

Zacks Small Cap Research

a month ago

DWTX: Phase 2 Long COVID Results Expected Soon

Thomson Reuters StreetEvents

2 months ago

Q3 2024 Dogwood Therapeutics Inc Earnings Call

GuruFocus.com

2 months ago

Dogwood Therapeutics Inc (DWTX) Q3 2024 Earnings Call Highlights: Strategic Financing and ...

Dogwood Therapeutics Announces Third Quarter 2024 Financial Results

GlobeNewswire

2 months ago

Dogwood Therapeutics Announces Third Quarter 2024 Financial Results

Dogwood Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Thursday, November 7, 2024

GlobeNewswire

2 months ago

Dogwood Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Thursday, November 7, 2024

Dogwood Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

GlobeNewswire

2 months ago

Dogwood Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

DWTX: Virios Therapeutics Becomes Dogwood Therapeutics; Focus on Chemotherapy-Induced Neuropathic Pain…

Zacks Small Cap Research

2 months ago

DWTX: Virios Therapeutics Becomes Dogwood Therapeutics; Focus on Chemotherapy-Induced Neuropathic Pain…

Share on Social Networks: